Molecular Tumor Board at the Center for Personalized Medicine Tübingen

NCT03503149 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2018-04-19

No results posted yet for this study

Summary

Molecular Tumor Board at the Center for Personalized Medicine

Conditions

Interventions

OTHER

no intervention

observational study

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Ghazaleh Tabatabai, Prof · University Hospital Tübingen

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2028-03-01
Completion
2028-03-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03503149 on ClinicalTrials.gov